Clinica de la Costa Ltda.

Barranquilla, Atlántico 80002

0 studies enrolling now · 9 studies all time

What they study most

COVID-19, COVID-19 Disease, Cardiovascular Disease, Clostridium Difficile Infection, Coronavirus Infection, Flaviviral Diseases, Flaviviridae Infections, Flavivirus Infections, RNA Virus Infections, Rheumatoid Arthritis, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Sickle Cell Disease

Studies at this site

• A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease — Stopped early
• A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises — Completed
• A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises — Stopped early
• VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents — Completed
• Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure — Stopped early
• A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection — Completed
• Clostridium Difficile Vaccine Efficacy Trial — Completed
• Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04) — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early